• MOQ 10-50 Piece(s)

hexaximrndtpa-hepb-ipv-hibrndiphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed) .

• MOQ 100 Piece(s)

pentavac sd/pfsrndiphtheria, tetanus, pertussis (whole cell), hepatitis b (rdna) and haemophilus type b conjugate vaccine (adsorbed) i.p. Indicationrnfor the prevention of serious childhood diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis b and haemophilus influenzae type b. Route of administrationrnintramuscular injection. Immunization schedulernfirst dose is given at 6 weeks or 10 weeks or 14 weeks of age second dose is given anytime between 12-18 months of age compositionrneach dose of 0.5 ml containsrndiphtheria toxoid � 25 lf (� 30 iu)rntetanus toxoid � 2.5 lf (� 40 iu)rnb. Pertussis (whole cell) � 16 ou (� 4.0 iu)*rnhbsag (rdna) � 10 mcgrnpurified capsular hib polysaccharide (prp)rnconjugated to tetanus toxoid (carrier protein) 10 mcgrn+++ adsorbed on aluminium phosphate, al � 1.25 mgrnpreservative: thiomersal 0.005% *the lower fiducial limit (p=0.95) of the estimated potency is not less than 2.0 iu. Adsorbed can be given at the age of 15-18 months. presentation:rnpentavac sd: 1 dose vial of 0.5 mlrnpentavac pfs: 1 x 0.5 ml - 1 dose pre-filled syringe

• MOQ 100 Piece(s)

Rabipur injectionicon glaxo smithkline pharmaceuticals ltd composition for rabipur injection rabies vaccine (2.5iu) primary uses of rabipur injection rabies.

• MOQ 2000 Piece(s)

triple antigenrndiphtheria, tetanus and pertussis vaccine (adsorbed) i.p indicationrnindicated for infants above the age of six weeks and of pre-school children against diphtheria, tetanus and pertussis (whooping cough). Route of administrationrnintramuscular injection immunization schedulernfirst 3 doses should be given 4 weeks apart at 6, 10 and 14 weeks. a booster dose can be given at the age of 15-18 months and also between the ages of 4 to 6 years. Compositionrneach single 0.5 ml dose containsrndiphtheria toxoid � 25 lf (� 30 iu)rntetanus toxoid � 5 lf (� 40 iu)rnb. Pertussis � 16 ou (� 4 iu)rnadsorbed on aluminium phosphate, al+++ � 1.25 mgrnpreservative: 0.005% thiomersalrnpresentation:rnbox of 10 ampoules of 0.5 ml eachrnbox of 10 md vials of 5 ml eachrnhomernabout usrnproductsrnproducts for overseasrnproducts for indiarnproduct listrnproduct pipeline

• MOQ 100 Piece(s)

Boostrix vaccineiconrnglaxo smithkline pharmaceuticals ltdrncomposition for boostrix vaccinerndiphtheria toxoid (2iu) + tetanus toxoid (20iu) + pertussis toxoid (8mcg) + pertactin (2.5mcg)rnprimary uses of boostrix vaccinerntetanus, pertussis, diphtheriarnmrp₹1098rn0.5 ml in 1 prefilled syringe.

• MOQ 50 Piece(s)

Cervarix VaccineiconrnGlaxo SmithKline Pharmaceuticals LtdrnComposition for Cervarix VaccinernHuman Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (NA) Primary uses of Cervarix VaccinernPrevention of HPV-Associated CancersrnMRP₹2405rn₹2405/Suspension for Injectionrn0.5 ml in 1 prefilled syringe

• MOQ 100 Piece(s)

Boostrix vaccineiconrnglaxo smithkline pharmaceuticals ltdrncomposition for boostrix vaccinerndiphtheria toxoid (2iu) + tetanus toxoid (20iu) + pertussis toxoid (8mcg) + pertactin (2.5mcg)rnprimary uses of boostrix vaccinerntetanus, pertussis, diphtheriarnmrp₹1098rn0.5 ml in 1 prefilled syringe.

• MOQ 100 Piece(s)

Biovac a vaccineiconrnwockhardt ltdrncomposition for biovac a vaccinernhepatitis a (6.5ccid50)rnprimary uses of biovac a vaccinernhepatitis a prophylaxisrnmrp₹1395rn0.5 ml in 1 vial.

• MOQ 50-100 Piece(s)

synflorix injection iconrnglaxo smithkline pharmaceuticals ltd composition for synflorix injectionrnpneumococcal polysaccharide vaccine (1mcg) primary uses of synflorix injectionrnpneumonia .

• MOQ 10-50 Piece(s)

menactraâ®rnmeningococcal (groups a, c, y and w-135) polysacchariderndiphtheria toxoid conjugate vaccinernsolution for intramuscular injection menactra is indicated for active immunization to prevent invasive meningococcalrndisease caused by neisseria meningitidis serogroups a, c, y and w-135. Menactra isrnapproved for use in individuals 9 months through 55 years of age. Menactra does notrnprevent n meningitidis serogroup b disease. (1) single-dose vial, 0.5 ml

• MOQ 50-100 Piece(s)

easy six vaccine icon panacea biotech ltd composition for easy six vaccine diphtheria immune globulin (30iu), hemophiliacs b conjugate vaccine (10mcg), pertussis toxoid (4iu), tetanus toxoid (60iu), poliomyelitis virus type 1 (40d antigen unit), poliomyelitis virus type 2 (8d antigen unit), poliomyelitis virus type 3 (8d antigen unit) icon prescription required primary uses of easy six vaccine infections, hemophiliacs influenza type b disease, pertussis 23930.5 ml in 1 vial.

• MOQ 100 Piece(s)

tresivacrnmeasles, mumps and rubella vaccine (live) i.p. (freeze-dried) indicationrnfor active immunization against measles, mumps and rubella in infants & children, adolescents and young adults at risk. Route of administrationrnsubcutaneous injection immunization schedulernfirst dose of mmr is given at 9 months of agernsecond dose of mmr is given anytime between 15-18 months rnthird dose of mmr is given anytime between 4-6 years of age. Compositionrnthe reconstituted vaccine contains in each single human dose of 0.5 ml:rnnot less than 1000 ccid50 of measles virusrnnot less than 5000 ccid50 of mumps virusrnnot less than 1000 ccid50 of rubella virusrnpresentation:rnbox of 10 single dose vials. box of 10 ampoules of 0.5 ml diluent provided separately